Michel Grangeorge

Title: Michel Grangeorge: Innovator in Human Albumin Solutions

Introduction

Michel Grangeorge is a notable inventor based in Vaugneray, France. He has made significant contributions to the field of biochemistry, particularly in the stabilization of human albumin solutions for therapeutic use. His innovative approach has the potential to enhance the safety and efficacy of medical treatments involving human albumin.

Latest Patents

Michel Grangeorge holds a patent for a process aimed at stabilizing human albumin solutions. The patent, titled "Process for stabilizing human albumin solutions and the solution obtained," outlines a method that involves adding a surfactant agent, such as Tween 80, Tween 20, Pluronic F68, or polyethylene glycol laurate, to the usual stabilizing formula. This addition is crucial for ensuring the stability of the solutions during heat treatment, particularly in the final container.

Career Highlights

Grangeorge is affiliated with Institut Merieux, a prominent organization known for its work in the field of health and biotechnology. His role at the institute has allowed him to focus on research and development in biopharmaceuticals, contributing to advancements in therapeutic solutions.

Collaborations

One of his notable collaborators is Pierre Fournier, with whom he has worked closely on various projects related to human albumin solutions. Their partnership has fostered innovation and has been instrumental in the development of new methodologies in the field.

Conclusion

Michel Grangeorge's work in stabilizing human albumin solutions represents a significant advancement in biochemistry and therapeutic applications. His contributions continue to impact the medical field positively, showcasing the importance of innovation in healthcare.